# Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/temsirolimus-interferon-alfa-or-both-for-advanced-renal-cell-carcinoma/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Gary R. Hudes,Michael A. Carducci,Piotr Tomczak,Janice Dutcher,Robert A. Figlin,Anil Kapoor,Elżbieta Starosławska,Jeffrey A. Sosman,David McDermott,I. Bodrogi,Zoran Kovačević,Vladimir Lesovoy,Ingo G.H. Schmidt‐Wolf,О. Л. Барбараш,Erhan Gökmen,Timothy E. O’Toole,Stephanie Lustgarten,Laurence Moore,Robert J. Motzer |
| Citations | 3,653 |
| DOI | 10.1056/nejmoa066838 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2153867442 |
| PMID | 17538086 |
| Type | article |
| Year | 2007 |

## Paper authors

- [Michael A. Carducci](https://scholariq.org/researchers/michael-a-carducci/)
- [Laurence Moore](https://scholariq.org/researchers/laurence-moore/)

## Paper journal

- [New England Journal of Medicine](https://scholariq.org/journals/new-england-journal-of-medicine/)

## Paper primary topic

- [Renal cell carcinoma treatment](https://scholariq.org/topics/renal-cell-carcinoma-treatment/)

## Paper topics

- [Renal cell carcinoma treatment](https://scholariq.org/topics/renal-cell-carcinoma-treatment/)
- [Tuberous Sclerosis Complex Research](https://scholariq.org/topics/tuberous-sclerosis-complex-research/)
- [PI3K/AKT/mTOR signaling in cancer](https://scholariq.org/topics/pi3k-akt-mtor-signaling-in-cancer/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.